Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

293.72
+0.34000.12%
Pre-market: 293.70-0.0200-0.01%08:34 EDT
Volume:1.64M
Turnover:484.56M
Market Cap:158.13B
PE:24.02
High:297.89
Open:295.49
Low:293.35
Close:293.38
52wk High:339.17
52wk Low:253.30
Shares:538.36M
Float Shares:536.99M
Volume Ratio:0.88
T/O Rate:0.31%
Dividend:9.26
Dividend Rate:3.15%
EPS(TTM):12.23
EPS(LYR):7.62
ROE:99.14%
ROA:7.51%
PB:21.29
PE(LYR):38.56

Loading ...

Royalty Pharma Stock (RPRX) Rises as it Seals $950M Cancer Royalties Deal with Amgen

TIPRANKS
·
45 mins ago

Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra

TIPRANKS
·
2 hours ago

Royalty Pharma Acquires Royalty Interest in Amgen's Imdelltra for $885 Million, with Option for Additional $65 Million Purchase

Reuters
·
2 hours ago

Royalty Pharma - Beone Will Retain China Commercial Rights to Imdelltra

THOMSON REUTERS
·
2 hours ago

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

THOMSON REUTERS
·
2 hours ago

BeOne Medicines AG Announces $950 Million Royalty Agreement with Royalty Pharma for IMDELLTRA Sales

Reuters
·
2 hours ago

Piper Sandler Adjusts Price Target on Amgen to $342 From $328, Maintains Overweight Rating

MT Newswires Live
·
2 hours ago

U.S. RESEARCH ROUNDUP-Amgen, Figma, Nordson

Reuters
·
5 hours ago

Amgen’s New Clinical Study: A Potential Game Changer in Lung Cancer Treatment

TIPRANKS
·
Aug 23

Amgen’s Promising Asthma Treatment: Rocatinlimab Study Update

TIPRANKS
·
Aug 23

Amgen’s AMG 193 Study: A New Hope for Advanced Thoracic Tumors

TIPRANKS
·
Aug 23

Amgen Inc. Announces Clinical Trial for Innovative LOCKTAC Molecule Targeting Cancer Enzyme PRMT5

Reuters
·
Aug 22

Cytokinetics Appoints Jim Daly to Board of Directors, Enhancing Commercial Expertise

Reuters
·
Aug 20

Rothschild & Co Redburn Adjusts Price Target on Amgen to $180 From $185, Maintains Sell Rating

MT Newswires Live
·
Aug 20

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 20

Amgen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Aug 19

UnitedHealth, Salesforce Share Gains Contribute To Dow's 213-Point Climb

Dow Jones
·
Aug 15

Daiwa Securities Adjusts Price Target on Amgen to $310 From $350, Maintains Outperform Rating

MT Newswires Live
·
Aug 15

Amgen (AMGN) Gets a Buy from Bernstein

TIPRANKS
·
Aug 15

Amgen Inc : Bernstein Cuts Target Price to $335 From $350

THOMSON REUTERS
·
Aug 14